These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Propionhydroxamic acid for the prophylaxis of recurrences of infection-induced renal stones. Mandressi A; Dormia G; Montanari E; Del Nero A; Trinchieri A; Zanetti G; Tombolini P; Pisani E Contrib Nephrol; 1987; 58():222-5. PubMed ID: 3691132 [No Abstract] [Full Text] [Related]
23. Symposium on renal lithiasis. Urinary tract infection and renal lithiasis. Cox CE Urol Clin North Am; 1974 Jun; 1(2):279-97. PubMed ID: 4372767 [No Abstract] [Full Text] [Related]
24. [Use of a urease inhibitor, propionohydroxamic acid, in the treatment and prevention of infectious renal lithiasis. A study of 19 patients]. Tizzani A; Casetta G; Giona C; Piana P; Frea B Minerva Urol Nefrol; 1986; 38(3):239-49. PubMed ID: 3810384 [No Abstract] [Full Text] [Related]
25. [Surgical aspects of coralliform lithiasis. Our experience]. Rioja L; Minguez J; Ibarz J; Esclarin M; Nogueras M; Sanz J; Gómez Pereda R Actas Urol Esp; 1977; 1(6):297-302. PubMed ID: 615437 [No Abstract] [Full Text] [Related]
26. New treatment for struvite urinary stones. Smith LH N Engl J Med; 1984 Sep; 311(12):792-4. PubMed ID: 6472369 [No Abstract] [Full Text] [Related]
27. [Kidney lithiasis: study of various lithogenous factors and criteria for treatment]. Aboulker P; Thomas J; Steg A Clin Ter; 1972 Oct; 63(1):3-16. PubMed ID: 4643434 [No Abstract] [Full Text] [Related]
28. [Acetylhydroxamic acid in the treatment of nephrolithiasis, caused by infection with urease forming microorganisms]. Lorenz J; Lorenz K; Dabrowska B; Kowal R Z Urol Nephrol; 1989 Dec; 82(12):685-9. PubMed ID: 2698024 [TBL] [Abstract][Full Text] [Related]
29. Clinical evaluation of a new antilithiatic drug, "Debelysin". Krzeski T; Borówka A; Gustowski W; Atal CK; Orkiszewska A Pol J Pharmacol Pharm; 1983; 35(1):1-6. PubMed ID: 6889184 [TBL] [Abstract][Full Text] [Related]
31. [Oral dissolution and prevention of recurrences of uric-acid stones in the kidney by oral medication]. Makrigiannis D; Gaca A Dtsch Med Wochenschr; 1970 Jun; 95(26):1383-7 passim. PubMed ID: 4393109 [No Abstract] [Full Text] [Related]
32. Corynebacterium urealyticum (CDC Group D2) associated with staghorn calculus: treatment by percutaneous debulking and chemolysis. Nadler RB; Hoffman TA; McClennan BL; Clayman RV J Endourol; 1996 Feb; 10(1):31-4. PubMed ID: 9156691 [TBL] [Abstract][Full Text] [Related]
33. A randomized trial of acetohydroxamic acid for the treatment and prevention of infection-induced urinary stones in spinal cord injury patients. Griffith DP; Khonsari F; Skurnick JH; James KE J Urol; 1988 Aug; 140(2):318-24. PubMed ID: 3294442 [TBL] [Abstract][Full Text] [Related]
34. [Treatment of uric lithiasis with citrates]. Vargas F; Vargas R; Tallman B; Vivanco C; Neira N Rev Med Chil; 1970 Mar; 98(3):143-6. PubMed ID: 5471168 [No Abstract] [Full Text] [Related]
35. [On dissolution and prevention of urate calculi]. Scultéty S; Balogh ES Z Urol Nephrol; 1967 Dec; 60(12):843-52. PubMed ID: 5596649 [No Abstract] [Full Text] [Related]
36. [Coralliform calculi and recurrent urinary infection: a case of newberyite calculi (MgHPO4.3H2O)]. Uebelhart D; Wisard M; Véry JM Schweiz Med Wochenschr; 1984 Nov; 114(47):1689-94. PubMed ID: 6393327 [TBL] [Abstract][Full Text] [Related]